PMID- 23682103
OWN - NLM
STAT- MEDLINE
DCOM- 20131118
LR  - 20211021
IS  - 1098-660X (Electronic)
IS  - 0095-1137 (Print)
IS  - 0095-1137 (Linking)
VI  - 51
IP  - 6
DP  - 2013 Jun
TI  - Reply to "Calibration technologies for correct determination of Epstein-Barr 
      Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by 
      use of real-time-PCR-based assays".
PG  - 2014
LID - 10.1128/JCM.00545-13 [doi]
FAU - Bounaadja, Lotfi
AU  - Bounaadja L
FAU - Piret, Jocelyne
AU  - Piret J
FAU - Goyette, Nathalie
AU  - Goyette N
FAU - Boivin, Guy
AU  - Boivin G
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - J Clin Microbiol
JT  - Journal of clinical microbiology
JID - 7505564
RN  - 0 (Antiviral Agents)
SB  - IM
CON - J Clin Microbiol. 2013 Apr;51(4):1244-6. PMID: 23325820
CON - J Clin Microbiol. 2013 Jun;51(6):2013. PMID: 23682102
MH  - Antiviral Agents/*pharmacology
MH  - Herpesvirus 4, Human/*drug effects
MH  - Herpesvirus 6, Human/*drug effects
MH  - Herpesvirus 8, Human/*drug effects
MH  - Humans
MH  - Real-Time Polymerase Chain Reaction/*methods
PMC - PMC3716044
EDAT- 2013/05/18 06:00
MHDA- 2013/11/19 06:00
PMCR- 2013/12/01
CRDT- 2013/05/18 06:00
PHST- 2013/05/18 06:00 [entrez]
PHST- 2013/05/18 06:00 [pubmed]
PHST- 2013/11/19 06:00 [medline]
PHST- 2013/12/01 00:00 [pmc-release]
AID - 51/6/2014 [pii]
AID - 00545-13 [pii]
AID - 10.1128/JCM.00545-13 [doi]
PST - ppublish
SO  - J Clin Microbiol. 2013 Jun;51(6):2014. doi: 10.1128/JCM.00545-13.